用于治疗和实验室用途的人造血液:我们目前的进展如何?
Artificial blood for therapeutic and laboratory usage: Where do we stand?
作者信息
Ray Pulak Kumar, Kumar Pawan, Roy Somnath, Das Arup Kumar, Das Prasanta Kumar
机构信息
Department of Mechanical Engineering, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Advanced Technology Development Centre, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
出版信息
Biomicrofluidics. 2024 Sep 25;18(5):051505. doi: 10.1063/5.0186931. eCollection 2024 Sep.
The scarcity of blood for transfusion purposes has been widely acknowledged. Surgical therapeutic processes, war zones, and post-disaster treatments demand a huge amount of blood. Modern-day laboratories also require blood for bioengineering experimentation. Therefore, an artificially devised solution capable of mimicking the blood functions from biological and engineering relevance would be a noteworthy discovery of contemporary science. The experience drawn from discarded century-old blood substitutes has led us to technologically more advanced present-day solutions, which are better at carrying out the physiological functions of blood. Aiming at safety, stability, non-toxicity, and compatibility in terms of immuno-response, a remarkable number of substitutes are being tried to mimic the physiological properties and functions of red blood cells, platelets, plasma, and white blood cells. Despite significant efforts and time devoted, for transfusion, no product so far has been able to replace natural blood. This article puts together the important developments in blood substitutes that have evolved over the years, including substitutes for clinical as well as engineering requirements. It also points out the recent endeavors of synthesizing blood cells through modern synthetic routes. It has been highlighted that none of the blood substitutes have achieved the required efficacy so that they can be used . Finally, the emerging trends and future research needs have been stressed upon.
输血用血的短缺已得到广泛认可。外科治疗过程、战区和灾后治疗都需要大量血液。现代实验室在生物工程实验中也需要血液。因此,一种能够从生物学和工程学角度模拟血液功能的人工设计解决方案将是当代科学的一项重大发现。从废弃的百年老血替代品中吸取的经验,使我们得到了技术上更先进的现代解决方案,这些方案在执行血液的生理功能方面表现更佳。为了实现安全性、稳定性、无毒性以及免疫反应方面的兼容性,人们尝试了大量替代品来模拟红细胞、血小板、血浆和白细胞的生理特性和功能。尽管投入了大量精力和时间,但就输血而言,迄今为止还没有任何产品能够替代天然血液。本文汇总了多年来血液替代品的重要发展,包括满足临床和工程需求的替代品。它还指出了通过现代合成路线合成血细胞的最新努力。需要强调的是,目前还没有一种血液替代品达到可投入使用所需的功效。最后,着重介绍了新兴趋势和未来的研究需求。
相似文献
Biomicrofluidics. 2024-9-25
Cochrane Database Syst Rev. 2008-7-16
Health Technol Assess. 2024-10
Cochrane Database Syst Rev. 2016-10-13
Autism Adulthood. 2024-12-2
本文引用的文献
Front Bioeng Biotechnol. 2022-10-12
Hamostaseologie. 2022-2
Mol Cancer. 2022-2-21
Platelets. 2022-1-2
Pflugers Arch. 2021-2